4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide

4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide structure

CAS No.: 301692-84-2

Chemical Name:: 4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide

Synonyms: 4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide;Benzenesulfonamide, 4-(4,5-dihydro-5,5-dimethyl-4-oxo-3-phenyl-2-furanyl)-;4-(5,5-diMethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzene-1-sulfonaMide

CBNumber:: CB52535903

Molecular Formula:: C18H17NO4S

Molecular Weight:: 343.4

MDL Number:: MFCD22570960

MOL File:: 301692-84-2.mol

Request For Quotation

4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide Properties

Melting point	180-182 °C
Boiling point	524.8±60.0 °C(Predicted)
Density	1.314±0.06 g/cm3(Predicted)
pka	10.21±0.10(Predicted)

4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide Preparation Products And Raw materials

Raw materials

Preparation Products

4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide Suppliers

Global( 2)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Shanghai Sinch Parmaceuticals Tech. Co. Ltd.	+86-21-54098501	sales@sinch.com.cn	China	11605	64
guoyungurui	18162595016	3287908757@qq.com	China	10015	58

Supplier	Advantage
Shanghai Sinch Parmaceuticals Tech. Co. Ltd.	64
guoyungurui	58

301692-84-2(4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide)Related Search:

Vecabrutinib 4-(2,4-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 4-(5,5-dimethyl-4-oxo-3-m-tolyl-4,5-dihydrofuran-2-yl)benzenesulfonamide (3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide

(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one (3S,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide rel-(3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide

[1,3'-Bipiperidine]-4'-carboxamide, 1'-(6-amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo-, (3S,3'R,4'S)- 3(2H)-Furanone, 5-[4-[[(acetyloxy)methyl]thio]phenyl]-4-(3-fluorophenyl)-2,2-dimethyl- 4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 4-(4-fluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 2,2-dimethyl-5-(4-(methylthio)phenyl)-4-phenylfuran-3(2H)-one

(3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(3,4-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one (3R,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide

1of4

4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide 4-(5,5-diMethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzene-1-sulfonaMide Benzenesulfonamide, 4-(4,5-dihydro-5,5-dimethyl-4-oxo-3-phenyl-2-furanyl)- 301692-84-2